|05-16-2019 07:02 PM CET - Health & Medicine||
Rapid Growth of Recombinant Protein Market 2019: Top Key Vendors (Abcam, Abnova, Eli Lilly, Enzo Life Sciences, Merck KGaA, Novo Nordisk AS) | Global Forecast to 2024
Press release from: ProgMark
Global Recombinant Protein Market research report 2019 - 2024 provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.
Overview of the Global Recombinant Protein Market:
The report spread across 110 pages is an overview of the Global Recombinant Protein Market. These report study based on the Recombinant Protein Market. It is a complete overview of the market, covering various aspects prevailing market landscape. It accumulates comprehensive information and research methodologies.
The growth of the Recombinant Protein Market is attributed due to increased expenditure in R&D, the growing prevalence of chronic diseases, rising inclination toward biologics and Biosimilars, and advanced recombinant products.
Get a Sample Copy of this Report @ marketprognosis.com/sample-request/19726 .
The increase in R&D investment in Asia, particularly China, and the consecutive annual growth in R&D spending in North America indicates a period of stability, security, and healthy competition across industrial sectors. As per the 2016 Global R&D Funding Forecast, this year, sponsored by the Industrial Research Institute (IRI), Washington, DC, reveals that global R&D investments may increase by 3.5% in 2016, to a total of USD 1.948 trillion in purchasing power parity (PPP) values for more than 110 countries having significant R&D investments. Thus, increased research and R&D investments in the life sciences industry are augmenting the growth of the market.
Regionally, North America is expected to lead the Global Recombinant Protein Market, owing to the increased expenditure in research. The United States is anticipated to witness the highest growth, owing to the largest concentration of world-class research universities and academic medical centers. The R&D spending of the United States is around 2.7% of its gross domestic product (GDP). In 2014, the United States was leading the R&D investments in biotechnology and, since then, the US biotechnology research and investment has been growing at a steady rate. Development of new products and collaboration activities of biotechnology companies are likely to boost the growth of the recombinant protein market.
Industry Analysis: The recombinant protein market consists of several major players, including Eli Lilly and Company, Merck KGaA, and Novo Nordisk AS, among others. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them in strengthening their market position. For instance, in July 2018, the Abcam Merck together produced PD-L1 antibody for immuno-oncology research.
This comprehensive Recombinant Protein Market research report 2019 – 2024 includes a brief on these trends that can help the businesses operating in the industry to understand the market and strategize for their business expansion accordingly. The research report analyzes the market size, industry share, growth, key segments, CAGR and key drivers.
Major Key Players:
1 Abcam PLC
2 Abnova Corporation
3 Eli Lilly and Company
4 Enzo Life Sciences Inc.
5 Eurogentec (Kaneka Corporation)
6 Merck KGaA
7 Novo Nordisk AS
8 ProSpec-Tany TechnoGene Ltd and More………….
Purchase this report online with 110 Pages, Top Key Players Analysis and List of Tables & Figure @ marketprognosis.com/buyReport/19726 .
Table of Contents:
2 Global Recombinant Protein Market Research Methodology
3 Executive Summary
4 Global Recombinant Protein Market Dynamics
5 Global Recombinant Protein Market Segmentation
6 Competitive Landscape
7 Global Recombinant Protein Market Opportunities and Future Trends
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.
ProgMark Pvt. Ltd.
Thane – 421501
+1 973 241 5193
This release was published on openPR.
News-ID: 1742514 • Views: 250More releases